25 XP   0   0   10

Tonghua Dongbao Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Tonghua Dongbao Pharmaceutical Co Ltd together

PenkeI guess you are interested in Tonghua Dongbao Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tonghua Dongbao Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Tonghua Dongbao Pharmaceutical Co Ltd

I send you an email if I find something interesting about Tonghua Dongbao Pharmaceutical Co Ltd.

Quick analysis of Tonghua Dongbao Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Tonghua Dongbao Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.23
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.62
Expected worth in 1 year
¥4.96
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥3.03
Return On Investment
30.0%

For what price can you sell your share?

Current Price per Share
¥10.09
Expected price per share
¥9.82 - ¥12.48
How sure are you?
50%

1. Valuation of Tonghua Dongbao Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥10.09

Intrinsic Value Per Share

¥-2.24 - ¥2.42

Total Value Per Share

¥1.38 - ¥6.04

2. Growth of Tonghua Dongbao Pharmaceutical Co Ltd (5 min.)




Is Tonghua Dongbao Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$996.5m$904.4m$92m9.2%

How much money is Tonghua Dongbao Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$161.2m$218.4m-$57.1m-35.5%
Net Profit Margin38.0%56.9%--

How much money comes from the company's main activities?

3. Financial Health of Tonghua Dongbao Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Tonghua Dongbao Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Tonghua Dongbao Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Tonghua Dongbao Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Tonghua Dongbao Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Tonghua Dongbao Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Tonghua Dongbao Pharmaceutical Co Ltd is ¥10.09. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tonghua Dongbao Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tonghua Dongbao Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.62. Based on the TTM, the Book Value Change Per Share is ¥0.33 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.23 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.42 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tonghua Dongbao Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.080.8%0.080.8%0.111.1%0.080.8%0.060.6%
Usd Book Value Change Per Share0.050.5%0.050.5%0.030.3%0.040.4%0.040.4%
Usd Dividend Per Share0.060.6%0.060.6%0.080.8%0.040.4%0.030.3%
Usd Total Gains Per Share0.101.0%0.101.0%0.111.1%0.080.8%0.070.7%
Usd Price Per Share1.50-1.50-1.27-1.57-2.19-
Price to Earnings Ratio18.49-18.49-11.57-21.62-48.72-
Price-to-Total Gains Ratio14.29-14.29-11.82-22.58-44.60-
Price to Book Ratio2.99-2.99-2.79-3.88-8.31-
Price-to-Total Gains Ratio14.29-14.29-11.82-22.58-44.60-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.393429
Number of shares717
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.060.04
Usd Book Value Change Per Share0.050.04
Usd Total Gains Per Share0.100.08
Gains per Quarter (717 shares)75.0456.89
Gains per Year (717 shares)300.18227.54
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1168132290125102218
2335265590250205446
3503397890376307674
46715301190501409902
583866214906265121130
6100679517907516141358
7117492720908767161586
813411060239010028191814
915091192269011279212042
10167713252990125210242270

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.01.095.8%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.06.00.075.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%24.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%19.05.00.079.2%

Fundamentals of Tonghua Dongbao Pharmaceutical Co Ltd

About Tonghua Dongbao Pharmaceutical Co Ltd

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China. The company operates through Pharmaceutical Industry; Building Materials Industry; and Real Estate Industry segments. It offers human insulin raw materials and injection, insulin glargine raw materials and injection, insulin aspart API and injection, Zhennaoning capsules, and diabetes-related medical devices. Further, it provides insulin pen and needle injection system, blood sugar monitoring system, and online and offline patient management system. It offers building materials.Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.

Fundamental data was last updated by Penke on 2024-04-17 10:58:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Tonghua Dongbao Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Tonghua Dongbao Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Tonghua Dongbao Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 38.0% means that ¥0.38 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 38.0%. The company is making a huge profit. +2
  • The TTM is 38.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ38.0%TTM38.0%0.0%
TTM38.0%YOY56.9%-19.0%
TTM38.0%5Y39.3%-1.3%
5Y39.3%10Y34.1%+5.2%
1.1.2. Return on Assets

Shows how efficient Tonghua Dongbao Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tonghua Dongbao Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 15.0% Return on Assets means that Tonghua Dongbao Pharmaceutical Co Ltd generated ¥0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 15.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 15.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ15.0%TTM15.0%0.0%
TTM15.0%YOY23.4%-8.4%
TTM15.0%5Y17.9%-2.9%
5Y17.9%10Y15.9%+2.1%
1.1.3. Return on Equity

Shows how efficient Tonghua Dongbao Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tonghua Dongbao Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 16.2% Return on Equity means Tonghua Dongbao Pharmaceutical Co Ltd generated ¥0.16 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 16.2%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 16.2%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ16.2%TTM16.2%0.0%
TTM16.2%YOY24.2%-8.0%
TTM16.2%5Y18.9%-2.7%
5Y18.9%10Y18.0%+0.9%

1.2. Operating Efficiency of Tonghua Dongbao Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Tonghua Dongbao Pharmaceutical Co Ltd is operating .

  • Measures how much profit Tonghua Dongbao Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tonghua Dongbao Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY31.8%-31.8%
TTM-5Y28.7%-28.7%
5Y28.7%10Y29.9%-1.2%
1.2.2. Operating Ratio

Measures how efficient Tonghua Dongbao Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.78 means that the operating costs are ¥0.78 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 0.776. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.776. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.776TTM0.7760.000
TTM0.776YOY0.902-0.126
TTM0.7765Y0.838-0.062
5Y0.83810Y0.796+0.042

1.3. Liquidity of Tonghua Dongbao Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Tonghua Dongbao Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 5.41 means the company has ¥5.41 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 5.414. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.414. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.414TTM5.4140.000
TTM5.414YOY12.690-7.275
TTM5.4145Y8.342-2.928
5Y8.34210Y6.285+2.057
1.3.2. Quick Ratio

Measures if Tonghua Dongbao Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tonghua Dongbao Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.63 means the company can pay off ¥1.63 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 1.631. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.631. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.631TTM1.6310.000
TTM1.631YOY2.967-1.336
TTM1.6315Y2.456-0.825
5Y2.45610Y2.137+0.319

1.4. Solvency of Tonghua Dongbao Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Tonghua Dongbao Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tonghua Dongbao Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.07 means that Tonghua Dongbao Pharmaceutical Co Ltd assets are financed with 7.1% credit (debt) and the remaining percentage (100% - 7.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 0.071. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.071. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.071TTM0.0710.000
TTM0.071YOY0.030+0.042
TTM0.0715Y0.051+0.021
5Y0.05110Y0.120-0.070
1.4.2. Debt to Equity Ratio

Measures if Tonghua Dongbao Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tonghua Dongbao Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 7.7% means that company has ¥0.08 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The MRQ is 0.077. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.077. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.077TTM0.0770.000
TTM0.077YOY0.031+0.046
TTM0.0775Y0.054+0.023
5Y0.05410Y0.156-0.102

2. Market Valuation of Tonghua Dongbao Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Tonghua Dongbao Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Tonghua Dongbao Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 18.49 means the investor is paying ¥18.49 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The EOD is 17.225. Based on the earnings, the company is fair priced.
  • The MRQ is 18.488. Based on the earnings, the company is fair priced.
  • The TTM is 18.488. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD17.225MRQ18.488-1.263
MRQ18.488TTM18.4880.000
TTM18.488YOY11.570+6.918
TTM18.4885Y21.616-3.128
5Y21.61610Y48.724-27.108
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The EOD is 153.370. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 164.618. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 164.618. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD153.370MRQ164.618-11.248
MRQ164.618TTM164.6180.000
TTM164.618YOY49.270+115.348
TTM164.6185Y64.757+99.860
5Y64.75710Y59.395+5.363
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Tonghua Dongbao Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Tonghua Dongbao Pharmaceutical Co Ltd:

  • The EOD is 2.788. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.992. Based on the equity, the company is underpriced. +1
  • The TTM is 2.992. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.788MRQ2.992-0.204
MRQ2.992TTM2.9920.000
TTM2.992YOY2.794+0.198
TTM2.9925Y3.880-0.889
5Y3.88010Y8.306-4.426
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Tonghua Dongbao Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3350.3350%0.227+47%0.258+29%0.261+28%
Book Value Per Share--3.6203.6200%3.285+10%3.032+19%2.400+51%
Current Ratio--5.4145.4140%12.690-57%8.342-35%6.285-14%
Debt To Asset Ratio--0.0710.0710%0.030+140%0.051+41%0.120-41%
Debt To Equity Ratio--0.0770.0770%0.031+151%0.054+44%0.156-51%
Dividend Per Share--0.4230.4230%0.550-23%0.316+34%0.222+91%
Eps--0.5860.5860%0.793-26%0.576+2%0.441+33%
Free Cash Flow Per Share--0.0660.0660%0.186-65%0.257-74%0.187-65%
Free Cash Flow To Equity Per Share--0.0660.0660%-0.458+796%-0.081+223%-0.008+112%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--2.422--------
Intrinsic Value_10Y_min---2.244--------
Intrinsic Value_1Y_max--0.255--------
Intrinsic Value_1Y_min--0.072--------
Intrinsic Value_3Y_max--0.756--------
Intrinsic Value_3Y_min---0.039--------
Intrinsic Value_5Y_max--1.247--------
Intrinsic Value_5Y_min---0.430--------
Market Cap20115625477.120-7%21590904253.44021590904253.4400%18301970034.540+18%23026021906.362-6%31939585267.056-32%
Net Profit Margin--0.3800.3800%0.569-33%0.393-3%0.341+11%
Operating Margin----0%0.318-100%0.287-100%0.299-100%
Operating Ratio--0.7760.7760%0.902-14%0.838-7%0.796-2%
Pb Ratio2.788-7%2.9922.9920%2.794+7%3.880-23%8.306-64%
Pe Ratio17.225-7%18.48818.4880%11.570+60%21.616-14%48.724-62%
Price Per Share10.090-7%10.83010.8300%9.180+18%11.400-5%15.849-32%
Price To Free Cash Flow Ratio153.370-7%164.618164.6180%49.270+234%64.757+154%59.395+177%
Price To Total Gains Ratio13.313-7%14.29014.2900%11.820+21%22.585-37%44.599-68%
Quick Ratio--1.6311.6310%2.967-45%2.456-34%2.137-24%
Return On Assets--0.1500.1500%0.234-36%0.179-16%0.159-5%
Return On Equity--0.1620.1620%0.242-33%0.189-14%0.180-10%
Total Gains Per Share--0.7580.7580%0.777-2%0.574+32%0.483+57%
Usd Book Value--996568892.090996568892.0900%904496109.133+10%843911292.489+18%668553333.991+49%
Usd Book Value Change Per Share--0.0460.0460%0.031+47%0.036+29%0.036+28%
Usd Book Value Per Share--0.5000.5000%0.454+10%0.419+19%0.331+51%
Usd Dividend Per Share--0.0580.0580%0.076-23%0.044+34%0.031+91%
Usd Eps--0.0810.0810%0.110-26%0.080+2%0.061+33%
Usd Free Cash Flow--18112875.12518112875.1250%51299464.500-65%72037230.182-75%52426115.691-65%
Usd Free Cash Flow Per Share--0.0090.0090%0.026-65%0.036-74%0.026-65%
Usd Free Cash Flow To Equity Per Share--0.0090.0090%-0.063+796%-0.011+223%-0.001+112%
Usd Market Cap2777967878.390-7%2981703877.4002981703877.4000%2527502061.770+18%3179893625.269-6%4410856725.380-32%
Usd Price Per Share1.393-7%1.4961.4960%1.268+18%1.574-5%2.189-32%
Usd Profit--161278057.387161278057.3870%218459248.813-26%160171237.570+1%122742257.698+31%
Usd Revenue--424714953.634424714953.6340%383704367.474+11%408529758.633+4%347707214.758+22%
Usd Total Gains Per Share--0.1050.1050%0.107-2%0.079+32%0.067+57%
 EOD+4 -4MRQTTM+0 -0YOY+13 -225Y+19 -1610Y+22 -13

3.2. Fundamental Score

Let's check the fundamental score of Tonghua Dongbao Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1517.225
Price to Book Ratio (EOD)Between0-12.788
Net Profit Margin (MRQ)Greater than00.380
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.631
Current Ratio (MRQ)Greater than15.414
Debt to Asset Ratio (MRQ)Less than10.071
Debt to Equity Ratio (MRQ)Less than10.077
Return on Equity (MRQ)Greater than0.150.162
Return on Assets (MRQ)Greater than0.050.150
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Tonghua Dongbao Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.991
Ma 20Greater thanMa 5010.245
Ma 50Greater thanMa 10010.216
Ma 100Greater thanMa 20010.342
OpenGreater thanClose10.180
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Interest Income  6,601-2,5004,1013,9718,0715,87113,943-25,621-11,678



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets7,771,367
Total Liabilities555,082
Total Stockholder Equity7,211,199
 As reported
Total Liabilities 555,082
Total Stockholder Equity+ 7,211,199
Total Assets = 7,771,367

Assets

Total Assets7,771,367
Total Current Assets2,816,355
Long-term Assets4,955,012
Total Current Assets
Cash And Cash Equivalents 1,104,204
Short-term Investments 55,516
Net Receivables 793,065
Inventory 705,346
Other Current Assets 38,304
Total Current Assets  (as reported)2,816,355
Total Current Assets  (calculated)2,696,436
+/- 119,919
Long-term Assets
Property Plant Equipment 2,670,682
Intangible Assets 1,338,255
Long-term Assets Other 355,476
Long-term Assets  (as reported)4,955,012
Long-term Assets  (calculated)4,364,413
+/- 590,599

Liabilities & Shareholders' Equity

Total Current Liabilities520,161
Long-term Liabilities34,921
Total Stockholder Equity7,211,199
Total Current Liabilities
Short Long Term Debt 150,000
Accounts payable 115,903
Other Current Liabilities 1,663
Total Current Liabilities  (as reported)520,161
Total Current Liabilities  (calculated)267,566
+/- 252,595
Long-term Liabilities
Long-term Liabilities  (as reported)34,921
Long-term Liabilities  (calculated)0
+/- 34,921
Total Stockholder Equity
Retained Earnings 3,697,417
Total Stockholder Equity (as reported)7,211,199
Total Stockholder Equity (calculated)3,697,417
+/- 3,513,782
Other
Capital Stock1,993,617
Common Stock Shares Outstanding 1,993,617
Net Invested Capital 7,361,199
Net Working Capital 2,296,194
Property Plant and Equipment Gross 2,670,682



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
1,469,113
1,456,506
1,568,533
1,795,126
1,806,248
1,884,953
1,967,111
2,268,966
2,171,286
2,251,440
2,186,335
2,377,343
2,380,120
2,694,453
2,956,219
3,788,130
4,675,008
4,752,716
5,463,327
5,349,910
5,803,260
6,520,102
6,750,314
7,771,367
7,771,3676,750,3146,520,1025,803,2605,349,9105,463,3274,752,7164,675,0083,788,1302,956,2192,694,4532,380,1202,377,3432,186,3352,251,4402,171,2862,268,9661,967,1111,884,9531,806,2481,795,1261,568,5331,456,5061,469,113
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,633,871
2,209,783
2,239,978
2,273,232
1,926,634
1,922,421
2,162,461
2,056,413
2,816,355
2,816,3552,056,4132,162,4611,922,4211,926,6342,273,2322,239,9782,209,7831,633,871000000000000000
       Cash And Cash Equivalents 
9,836
6,091
19,039
4,129
14,299
28,339
8,925
9,501
18,646
46,702
62,776
243,969
124,599
216,058
201,876
212,208
235,629
336,435
355,983
368,013
593,375
865,040
788,063
1,104,204
1,104,204788,063865,040593,375368,013355,983336,435235,629212,208201,876216,058124,599243,96962,77646,70218,6469,5018,92528,33914,2994,12919,0396,0919,836
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
400,000
312,000
323,000
0
150,369
37,000
58,462
55,516
55,51658,46237,000150,3690323,000312,000400,0000000000000000000
       Net Receivables 
642,283
519,740
612,948
629,422
568,693
523,025
410,786
402,435
460,782
441,828
412,375
479,794
387,847
396,221
430,520
415,751
476,658
558,075
650,120
697,086
510,449
559,473
422,412
793,065
793,065422,412559,473510,449697,086650,120558,075476,658415,751430,520396,221387,847479,794412,375441,828460,782402,435410,786523,025568,693629,422612,948519,740642,283
       Inventory 
72,962
98,459
95,869
126,556
140,599
139,779
140,090
145,472
145,619
170,111
187,411
197,780
232,995
343,779
629,583
954,772
1,047,948
973,916
901,024
628,759
537,578
537,918
653,895
705,346
705,346653,895537,918537,578628,759901,024973,9161,047,948954,772629,583343,779232,995197,780187,411170,111145,619145,472140,090139,779140,599126,55695,86998,45972,962
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,465,226
2,512,738
3,190,095
3,423,276
3,880,839
4,357,641
4,693,901
4,955,012
4,955,0124,693,9014,357,6413,880,8393,423,2763,190,0952,512,7382,465,2260000000000000000
       Property Plant Equipment 
515,230
622,272
673,091
732,064
1,101,277
886,600
1,107,663
1,241,372
1,253,425
1,204,651
1,171,641
1,110,113
1,263,084
1,288,370
1,279,865
1,586,928
1,851,379
1,873,414
1,959,727
2,111,006
2,287,572
2,392,107
2,678,424
2,670,682
2,670,6822,678,4242,392,1072,287,5722,111,0061,959,7271,873,4141,851,3791,586,9281,279,8651,288,3701,263,0841,110,1131,171,6411,204,6511,253,4251,241,3721,107,663886,6001,101,277732,064673,091622,272515,230
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
179,182
319,636
338,575
326,245
0
0
0
0
0
00000326,245338,575319,636179,182000000000000000
       Intangible Assets 
32,971
34,741
30,579
31,239
31,973
15,060
86,106
87,174
65,123
55,593
54,010
46,477
39,229
36,065
56,292
49,609
198,732
193,608
388,574
472,570
608,757
796,649
1,069,084
1,338,255
1,338,2551,069,084796,649608,757472,570388,574193,608198,73249,60956,29236,06539,22946,47754,01055,59365,12387,17486,10615,06031,97331,23930,57934,74132,971
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,754
38,447
420,576
373,124
418,573
569,582
425,419
355,476
355,476425,419569,582418,573373,124420,57638,44736,7540000000000000000
> Total Liabilities 
44,104
77,960
205,519
393,949
480,119
544,229
691,131
734,971
737,660
624,745
453,749
299,373
388,923
678,228
795,715
1,309,110
729,763
215,295
729,058
341,099
243,801
299,874
200,740
555,082
555,082200,740299,874243,801341,099729,058215,295729,7631,309,110795,715678,228388,923299,373453,749624,745737,660734,971691,131544,229480,119393,949205,51977,96044,104
   > Total Current Liabilities 
44,062
76,296
153,565
343,052
379,789
450,204
375,522
421,573
424,762
321,229
169,194
163,370
136,028
375,037
460,653
1,026,729
639,033
174,987
691,402
304,847
208,183
268,552
162,053
520,161
520,161162,053268,552208,183304,847691,402174,987639,0331,026,729460,653375,037136,028163,370169,194321,229424,762421,573375,522450,204379,789343,052153,56576,29644,062
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
410,000
0
450,000
125,000
0
0
0
0
0000125,000450,0000410,0000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
410,000
0
450,000
125,000
0
0
0
150,000
150,000000125,000450,0000410,0000000000000000000
       Accounts payable 
28,738
29,276
39,670
40,700
45,211
44,415
43,138
40,843
49,537
40,695
46,654
37,765
30,775
38,878
51,988
53,195
90,501
61,287
131,962
69,152
68,174
74,999
80,858
115,903
115,90380,85874,99968,17469,152131,96261,28790,50153,19551,98838,87830,77537,76546,65440,69549,53740,84343,13844,41545,21140,70039,67029,27628,738
       Other Current Liabilities 
11,924
43,820
110,695
53,152
63,078
67,939
80,684
56,680
53,525
57,534
58,540
32,605
26,253
53,159
98,665
84,695
100,327
94,630
86,616
91,485
124,021
161,809
70,166
1,663
1,66370,166161,809124,02191,48586,61694,630100,32784,69598,66553,15926,25332,60558,54057,53453,52556,68080,68467,93963,07853,152110,69543,82011,924
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90,730
40,308
37,657
36,252
35,619
31,322
38,687
34,921
34,92138,68731,32235,61936,25237,65740,30890,7300000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
60,000
0
0
0
0
0
0
0
000000060,0000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54,911
75,230
96,636
149,319
219,425
357,832
447,288
607,248
0
0607,248447,288357,832219,425149,31996,63675,23054,911000000000000000
> Total Stockholder Equity
1,417,941
1,372,059
1,322,034
1,358,169
1,279,920
1,296,115
1,233,059
1,491,991
1,393,784
1,592,887
1,699,645
2,046,027
1,961,704
1,991,181
2,137,748
2,459,317
3,939,220
4,527,850
4,724,292
5,000,395
5,553,989
6,214,879
6,544,263
7,211,199
7,211,1996,544,2636,214,8795,553,9895,000,3954,724,2924,527,8503,939,2202,459,3172,137,7481,991,1811,961,7042,046,0271,699,6451,592,8871,393,7841,491,9911,233,0591,296,1151,279,9201,358,1691,322,0341,372,0591,417,941
   Common Stock
324,493
324,493
324,493
324,493
324,493
324,493
368,572
368,572
368,572
479,144
574,972
776,213
776,213
931,455
1,030,101
1,135,831
1,421,933
1,711,296
2,033,989
2,033,989
2,033,989
2,033,989
1,993,679
0
01,993,6792,033,9892,033,9892,033,9892,033,9891,711,2961,421,9331,135,8311,030,101931,455776,213776,213574,972479,144368,572368,572368,572324,493324,493324,493324,493324,493324,493
   Retained Earnings 
234,459
189,999
138,489
167,778
87,625
100,260
110,509
212,221
252,792
320,112
482,730
808,825
708,331
716,493
960,205
1,144,134
1,330,725
1,598,505
1,752,592
2,157,000
2,679,235
3,566,555
4,052,665
3,697,417
3,697,4174,052,6653,566,5552,679,2352,157,0001,752,5921,598,5051,330,7251,144,134960,205716,493708,331808,825482,730320,112252,792212,221110,509100,26087,625167,778138,489189,999234,459
   Capital Surplus 000000000000000000000000
   Treasury Stock0000000-16,500-28,875-28,87500000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,148
3,272
4,825
8,251
7,483
6,939
6,386
0
06,3866,9397,4838,2514,8253,2721,1480000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,075,416
Cost of Revenue-612,771
Gross Profit2,462,6452,462,645
 
Operating Income (+$)
Gross Profit2,462,645
Operating Expense-1,772,833
Operating Income1,302,584689,813
 
Operating Expense (+$)
Research Development104,959
Selling General Administrative956,525
Selling And Marketing Expenses0
Operating Expense1,772,8331,061,484
 
Net Interest Income (+$)
Interest Income-11,678
Interest Expense-4,535
Other Finance Cost-21,789
Net Interest Income5,576
 
Pretax Income (+$)
Operating Income1,302,584
Net Interest Income5,576
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,365,8971,302,584
EBIT - interestExpense = -4,535
1,167,835
1,172,370
Interest Expense4,535
Earnings Before Interest and Taxes (EBIT)01,370,432
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax1,365,897
Tax Provision-197,974
Net Income From Continuing Ops1,167,9221,167,922
Net Income1,167,835
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-5,576
 

Technical Analysis of Tonghua Dongbao Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tonghua Dongbao Pharmaceutical Co Ltd. The general trend of Tonghua Dongbao Pharmaceutical Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tonghua Dongbao Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tonghua Dongbao Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 11.02 < 11.09 < 12.48.

The bearish price targets are: 9.9 > 9.88 > 9.82.

Tweet this
Tonghua Dongbao Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tonghua Dongbao Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tonghua Dongbao Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tonghua Dongbao Pharmaceutical Co Ltd. The current macd is 0.00386804.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Tonghua Dongbao Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Tonghua Dongbao Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Tonghua Dongbao Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Tonghua Dongbao Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartTonghua Dongbao Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tonghua Dongbao Pharmaceutical Co Ltd. The current adx is 12.22.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Tonghua Dongbao Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Tonghua Dongbao Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tonghua Dongbao Pharmaceutical Co Ltd. The current sar is 10.60.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Tonghua Dongbao Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tonghua Dongbao Pharmaceutical Co Ltd. The current rsi is 47.99. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Tonghua Dongbao Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartTonghua Dongbao Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tonghua Dongbao Pharmaceutical Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tonghua Dongbao Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Tonghua Dongbao Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartTonghua Dongbao Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tonghua Dongbao Pharmaceutical Co Ltd. The current cci is -45.09457425.

Tonghua Dongbao Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartTonghua Dongbao Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tonghua Dongbao Pharmaceutical Co Ltd. The current cmo is -6.14647239.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Tonghua Dongbao Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartTonghua Dongbao Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tonghua Dongbao Pharmaceutical Co Ltd. The current willr is -66.23376623.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Tonghua Dongbao Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Tonghua Dongbao Pharmaceutical Co Ltd Daily Williams %R ChartTonghua Dongbao Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tonghua Dongbao Pharmaceutical Co Ltd.

Tonghua Dongbao Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tonghua Dongbao Pharmaceutical Co Ltd. The current atr is 0.33978656.

Tonghua Dongbao Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartTonghua Dongbao Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tonghua Dongbao Pharmaceutical Co Ltd. The current obv is 333,581,552.

Tonghua Dongbao Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartTonghua Dongbao Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tonghua Dongbao Pharmaceutical Co Ltd. The current mfi is 42.94.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Tonghua Dongbao Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartTonghua Dongbao Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tonghua Dongbao Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Tonghua Dongbao Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tonghua Dongbao Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.991
Ma 20Greater thanMa 5010.245
Ma 50Greater thanMa 10010.216
Ma 100Greater thanMa 20010.342
OpenGreater thanClose10.180
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Tonghua Dongbao Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Tonghua Dongbao Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tonghua Dongbao Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tonghua Dongbao Pharmaceutical Co Ltd

I send you an email if I find something interesting about Tonghua Dongbao Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Tonghua Dongbao Pharmaceutical Co Ltd.

Receive notifications about Tonghua Dongbao Pharmaceutical Co Ltd in your mailbox!